Regenxbio RGNX Enterprise value

Enterprise value at other companies

Regeneron PharmaceuticalsREGN

$65.61B+15.0%

Sarepta Therapeutics, Inc.SRPT

$1.52B-2.9%

BiogenBIIB

$38.17B+70.8%

BioMarin PharmaceuticalsBMRN

$14.37B+45.5%

EyePoint, Inc.EYPT

$1.11B+90.1%

Ultragenyx PharmaceuticalRARE

$1.83B-51.1%

FAQ

What is Regenxbio's enterprise value?

Regenxbio (RGNX) reported enterprise value of $651.8M in Q2 2026.

How has Regenxbio's enterprise value changed year-over-year?

Regenxbio's enterprise value increased by 51.8% year-over-year, from $429.47M to $651.8M.

What is the long-term trend for Regenxbio's enterprise value?

Over 5 years (2020 to 2025), Regenxbio's enterprise value has grown at a -14.4% compound annual growth rate (CAGR), from $1.67B to $768.01M.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.